Ua hōʻike ʻia kahi noiʻi hou hiki i ka CBD ke kōkua i ka hopohopo i nā ʻōpio a me nā ʻōpio. Ma hope o ka manawa mālama 12-wiki, ua hōʻike nā kumuhana i ka 42,6% hoʻemi i ka hopohopo.
He liʻiliʻi ke aʻo ʻana, a ʻōlelo ka poʻe loea e pono ai ka noiʻi hou aku. cannabidiol, a i ʻole CBD - ka mea non-psychoactive i ka cannabis - hiki ke lilo i mea lapaʻau hoʻohiki no ka hopohopo kūʻē i ka mālama ʻana i nā ʻōpio a me nā ʻōpio, kahi hōʻike noiʻi Australia hou.
3 mahina CBD mālama ʻia
Ma hope o 12 mau pule o ka mālama ʻana i ka CBD, ua hōʻike nā mea noiʻi mai 12 a 25 mau makahiki i ka awelika 42,6% ka emi ʻana o ka hopohopo a me ke kīnā i hoʻohālikelike ʻia me ka mālama mua. Ua ʻike ʻia i loko o ke aʻo ʻana i alakaʻi ʻia e ka Australian Youth Mental Health Service a me Orygen Research Institute. Ua lawe nā mea noiʻi ma waena o 200 a me 800 mg o CBD i kēlā me kēia lā, e pili ana i ka ʻike pono. Ua paʻi ʻia ke aʻo ʻana i ka pule i hala ma ka Journal of Clinical Psychiatry.
Ua hoʻohana ka poʻe noiʻi i ʻelua mau pālākiō no ka helu ʻana i ka maikaʻi o ka mālama ʻana: nā loiloi ponoʻī (he 42,6% ka emi ʻana o nā hōʻailona hopohopo) a me ka Hamilton Anxiety Rating i hoʻopaʻa ʻia, i hoʻopaʻa ʻia he 50,7% ka emi ʻana o ka nui o ka hopohopo.
ʻO ke aʻo ʻana he 31 wale nō i komo, akā ua kau nui ʻia i ka poʻe i hōʻike ʻole i ka holomua me nā lāʻau hopohopo ʻē aʻe, me ka liʻiliʻi ʻelima me nā hui cognitive behavioral therapy (CBT). Eia naʻe, ua hoʻomau ka poʻe i komo i ka loaʻa ʻana o nā lāʻau lapaʻau CBT i loko o ka noiʻi 12-week. Ua hoʻolako kālā ʻia ke aʻo ʻana e ka Lambert Initiative for Cannabinoid Therapeutics ma ke Kulanui o Sydney, kahi papahana noiʻi kālā philanthropic i ʻike ʻia i ka hoʻomohala ʻana i nā lāʻau lapaʻau.
Haʻawina manaʻolana
He manaʻolana kēia akā ʻo ke aʻo mua ʻana, "wahi a Steven C. Hayes, Ph.D., he kauka psychologist a me ke kaukaʻi ma ke Kulanui o Nevada ma Reno, ʻaʻole i komo i ka noiʻi. "He hoʻomaka wale nō ke kaʻina hana wehe, akā pono ʻoe e hoʻomaka i kahi, a he hoʻomaka kēia."
"ʻO kahi liʻiliʻi o nā haʻawina, kekahi i hoʻomalu ʻia, ua hōʻike i nā pono o CBD i nā pilikia pili i ka hopohopo, no laila ua kūpono nā hopena me ka mea a mākou e ʻike nei e pili ana i ka cannabidiol," wahi āna.
ʻO kahi pōmaikaʻi o CBD ʻo ia ka mea he liʻiliʻi nā hopena ʻaoʻao ma nā haʻahaʻa haʻahaʻa a haʻahaʻa, e like me nā mea i hoʻohana ʻia i ke aʻo ʻana.
"Ua ʻike kā mākou noiʻi hoʻokele ʻaʻole hiki i ka cannabidiol ke kōkua wale i ka hōʻemi ʻana i nā hōʻailona hopohopo, akā ua ʻae maikaʻi ʻia - ʻo nā hopena ʻaoʻao maʻamau ʻo ia ka sedation haʻahaʻa a me ka luhi haʻahaʻa, akā ʻo ia ka manawa i hoʻonui ʻia ai nā doses. Ua nalowale kēia ma hope o kekahi mau lā, "wahi a ka mea kākau kumu alakaʻi Dr. Paul Amminger, PhD, ma kahi hoʻolaha paʻi. "ʻAʻole mākou i ʻike i nā hopena ʻaoʻao e like me nā manaʻo suicidal, irritability a i ʻole nā pilikia hiamoe, ʻaʻole ia he mea maʻamau i ka poʻe lawe SSRI."
Kāohi haʻawina
Ua hoʻomaikaʻi ka poʻe loea i ke aʻo ʻana no ka hoʻāʻo ʻana e loiloi i ka hoʻohana ʻana i nā lāʻau lapaʻau hou no ka mālama olakino noʻonoʻo i kahi pae pediatric a me nā ʻōpio ʻōpio. Akā naʻe, ua hoʻohewa lākou i nā ʻano o ka haʻawina.
No ka laʻana, ʻaʻole i koʻikoʻi ke aʻo ʻana i kāna wehewehe ʻana i ka "manaʻo kū'ē i ka mālama ʻana." "ʻO ka ʻōlelo ʻana he hopohopo 'kū'ē ka mālama ʻana i kahi keiki ma hope o ka loaʻa ʻana o nā hōʻailona hopohopo i hoʻomau ʻia ma hope o ʻelima mau manawa CBT he mea hoʻonui," wahi a Dr. ka luna o ka papahana o ka Cannabis Medicine, Science and Business Master's Program ma Sidney Kimmel Medical College ma Philadelphia.
Ua ʻae ʻo Hayes: "Inā loaʻa ka ʻike, e like me ka mea i manaʻo ʻia me nā pilikia hopohopo, ʻelima mau kau i kaupalena ʻia e ʻike i kahi hopena therapeutic," wahi āna. "ʻAʻole ʻike ʻia ka CBT i nā hopena ʻino, no laila ʻoi aku ka maikaʻi o ka hoʻāʻo ʻana."
Hōʻike ka hoʻohana ʻana o CBD i ka ʻōlelo hoʻohiki e kūʻē i ka hopohopo a me ke kaumaha
ʻOiai kēia mau palena, ʻo kēia mau ʻike he alakaʻi hoʻohiki no ka noiʻi hou aku.
"Ua ʻike mākou he ʻano kiʻekiʻe o ka ʻōnaehana endocannabinoid i ka lolo, e launa pū me nā neurotransmitters ʻē aʻe kahi e hōʻike ai ka hopohopo a me ke kaumaha," wahi a Worster iā Healthline. "I kēlā me kēia manawa, i nā hiʻohiʻona holoholona, hoʻoulu ʻo CBD i ka hoʻomaha ʻana i nā kūlana koʻikoʻi - no laila ʻike mākou aia kahi kumu pathophysiological ʻo CBD kahi lāʻau hoʻohiki no ka hopohopo." ʻO kēlā ʻōlelo, ua koi ʻo ia e makaʻala.
"ʻAʻole manaʻo kēia mau ʻike he panacea ʻo CBD a e hoʻōla ʻia kekahi me ka hopohopo ma ka hoʻohana ʻana," wahi āna. "Ke hāʻawi nei kēia haʻawina i ka ʻike nui aʻe, akā nui nā nīnau koʻikoʻi e koe."
Ua ʻae ʻo Amminger, ke alakaʻi aʻo i kēia. “Ua kaupalena ʻia kahi haʻawina hoʻokele hōʻailona wehe e kona hoʻolālā. He mea hōʻeuʻeu ka ʻike ʻana i kahi hopena lapaʻau i ka hui kūʻokoʻa lapaʻau, akā hiki ke lilo i hopena placebo, "i ʻōlelo ai ʻo ia i ka hoʻokuʻu ʻana. Ma hope o kēia mau ʻike mua, ua kāhea ʻo ia i kahi hoʻokolokolo hoʻāʻo nui aʻe.
Puna: healthline.com (EN)
